Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Authors
Timothy D. Folsom
Beau R. Webber (ORCID: https://orcid.org/0000-0002-3950-8747)
Branden S. Moriarity (ORCID: https://orcid.org/0000-0002-3031-3767)
Scott L. Baughan (ORCID: https://orcid.org/0000-0002-4998-7489)
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Timothy D. Folsom, Beau R. Webber, Branden S. Moriarity, Scott L. Baughan et al.
Journal
Frontiers in Immunology
Topics
Immune Cell Function and Interaction
article
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Timothy D. Folsom, Beau R. Webber, Branden S. Moriarity, Scott L. Baughan, Joshua Kreuger, Matt Johnson
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 17
Institutions
University of Minnesota (US), Twin Cities Orthopedics (US)
Funders
U.S. Department of Defense, Children's Cancer Research Fund, CURE Childhood Cancer, Fanconi Anemia Research Fund, Randy Shaver Cancer Research and Community Fund, National Institutes of Health